Gbm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-19
Clinical Trial Update: A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme [Phase 2, Phase 3]
Phase II/III study evaluating high-dose, intermittent sunitinib for recurrent glioblastoma multiforme is ongoing with unknown status.